GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Other Income (Expense)

ZYUS Life Sciences (TSXV:ZYUS) Other Income (Expense) : C$-26.97 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Other Income (Expense)?

ZYUS Life Sciences's other income expense for the ZYUS Life Sciences's pretax income for the three months ended in Mar. 2024 was C$0.08 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was C$-26.97 Mil.

ZYUS Life Sciences Other Income (Expense) Historical Data

The historical data trend for ZYUS Life Sciences's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Other Income (Expense) Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Other Income (Expense)
1.94 -2.96 -27.40

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.09 -2.51 0.02 -24.56 0.08

ZYUS Life Sciences Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-26.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ZYUS Life Sciences  (TSXV:ZYUS) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

ZYUS Life Sciences (TSXV:ZYUS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Other Income (Expense)
Comparable Companies
TSXV:DB XCNQ:HUGE TSX:CWEB XCNQ:GRIN TSX:MDP TSX:CRDL XCNQ:CXXI XCNQ:MMEN TSX:AVNT XCNQ:ACRG.A.U ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ZLSCF:USA
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
Website
https://www.zyus.com
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines